YiChang HEC shares involved in merger dealings disclosure

CICC Financial Trading Limited has disclosed its securities dealings in shares of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. The transactions, made under Rule 22 of the Hong Kong Code on Takeovers and Mergers, involved both purchase and sale of shares. On April 30, 2025, CICC Financial Trading Limited purchased 315,400 ordinary shares, with the transaction valued at USD 3,928,720.0000, at a high price of USD 12.5000 and low price of USD 12.3800 per share. Simultaneously, it also sold 315,400 shares, generating USD 3,934,641.5300, at a high price of USD 12.4751 and low price of USD 12.4751 per share. The purchase was attributed to hedging Delta 1 products due to unsolicited client-driven orders while the sale was associated with the creation of Delta 1 products stemming from unsolicited client-driven orders. CICC Financial Trading Limited is the principal trader in the deal and is owned by China International Capital Corporation Limited.